College of Pharmacy Pharmacy Education Consultation Office Certified professional certificate reflected in Mumaris+

Pharmacovigilance Program

The Pharmacovigilance Program is designed for healthcare professionals and individuals interested in medication safety and pharmacovigilance. The program aims to equip participants with the fundamental knowledge and practical skills required in pharmacovigilance, including adverse drug reaction reporting systems, signal management, medication errors, quality management, and cosmetic vigilance.

Program Description & Certificate

Professional Certificate

The program offers a professional certificate in the Fundamentals and Regulations of Pharmacovigilance, accredited by the Saudi Commission for Health Specialties.

Program Overview

Target Audience

Healthcare professionals and students from within and outside Princess Nourah bint Abdulrahman University

Program Structure

16 lectures and 4 activities

Delivery Mode

Blended (in-person and online)

Pharmacovigilance Program Objectives

Key Concepts & Principles

Develop a clear understanding of the key terms and fundamental principles related to pharmacovigilance.

Post-Marketing Surveillance

Identify key activities for post-marketing surveillance.

Detecting & Assessing Adverse Events

Demonstrate the ability to detect, report, and assess any adverse events, including harmful drug interactions, side effects, and medication errors related to the use of cosmetics or any pharmaceutical products.

Regulations & Legislation

Enhance understanding of regulatory requirements and legislation related to pharmacovigilance practices, both nationally and internationally.

Program Team

Program Director

Dr. Ghada Al-Shehri

Program Coordinators

Raneem Al-Zeer and Sultana Al-Shehri

Registration Details

Program Start Date

June 13, 2026

Registration Deadline

June 7, 2026

Registration Fees

Students: SAR 3,500 — Healthcare Professionals: SAR 5,000

Application and Payment

Payment Method

Bank transfer to the College of Pharmacy account.

Contact